Search

Author/Creator Cassier, Philippe A

1. 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study. (4th December 2020)

Authors:
Gonzalez-Martin, Antonio; Chung, Hyun Cheol; Saada-Bouzid, Esma; Yanez, Eduardo; Senellart, Hélène; Cassier, Philippe A; Basu, Bristi; Ghori, Razi; Kubiak, Peter; Smith, Alan; Norwood, Kevin; Lwin, Zarnie
Journal:
International journal of gynecological cancer
Issue:
Volume 30(2020)Supplement 4
Page Start:
A64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Issue 7 (July 2020)

Authors:
Heinrich, Michael C; Jones, Robin L; von Mehren, Margaret; Schöffski, Patrick; Serrano, César; Kang, Yoon-Koo; Cassier, Philippe A; Mir, Olivier; Eskens, Ferry; Tap, William D; Rutkowski, Piotr; Chawla, Sant P; Trent, Jonathan; Tugnait, Meera; Evans, Erica K; Lauz, Tamieka; Zhou, Teresa; Roche, M...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 7(2020)
Page Start:
935
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. Issue 8 (August 2015)

Authors:
Cassier, Philippe A; Italiano, Antoine; Gomez-Roca, Carlos A; Le Tourneau, Christophe; Toulmonde, Maud; Cannarile, Michael A; Ries, Carola; Brillouet, Anne; Müller, Claudia; Jegg, Anna-Maria; Bröske, Ann-Marie; Dembowski, Markus; Bray-French, Katharine; Freilinger, Christine; Meneses-Lorente, Geo...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 8(2015:Aug.)
Page Start:
949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. Issue 8 (August 2015)

Authors:
Cassier, Philippe A; Italiano, Antoine; Gomez-Roca, Carlos A; Le Tourneau, Christophe; Toulmonde, Maud; Cannarile, Michael A; Ries, Carola; Brillouet, Anne; Müller, Claudia; Jegg, Anna-Maria; Bröske, Ann-Marie; Dembowski, Markus; Bray-French, Katharine; Freilinger, Christine; Meneses-Lorente, Geo...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 8(2015:Aug.)
Page Start:
949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. CTIM-03. PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY. (14th November 2022)

Authors:
Baldini, Capucine; Cassier, Philippe A; Delord, Jean-Pierre; Simonelli, Matteo; Touat, Mehdi; Yao, Lili; Duic, J Paul; Gozman, Alexander; Marabelle, Aurelien
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study. (May 2022)

Authors:
Marabelle, Aurelien; Cassier, Philippe A; Fakih, Marwan; Kao, Steven; Nielsen, Dorte; Italiano, Antoine; Guren, Tormod Kyrre; van Dongen, Marloes G J; Spencer, Kristen; Bariani, Giovanni Mendonca; Ascierto, Paolo A; Santoro, Armando; Shah, Manisha; Asselah, Jamil; Iqbal, Syma; Takahashi, Shunji; ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 5(2022)
Page Start:
446
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors. Issue 2 (19th February 2021)

Authors:
Luke, Jason J; Barlesi, Fabrice; Chung, Ki; Tolcher, Anthony W; Kelly, Karen; Hollebecque, Antoine; Le Tourneau, Christophe; Subbiah, Vivek; Tsai, Frank; Kao, Steven; Cassier, Philippe A; Khasraw, Mustafa; Kindler, Hedy L; Fang, Hua; Fan, Frances; Allaire, Kathryn; Patel, Maulik; Ye, Shiming; Cha...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study. Issue 7 (July 2021)

Authors:
Gainor, Justin F; Curigliano, Giuseppe; Kim, Dong-Wan; Lee, Dae Ho; Besse, Benjamin; Baik, Christina S; Doebele, Robert C; Cassier, Philippe A; Lopes, Gilberto; Tan, Daniel S W; Garralda, Elena; Paz-Ares, Luis G; Cho, Byoung Chul; Gadgeel, Shirish M; Thomas, Michael; Liu, Stephen V; Taylor, Matth...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
959
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial. Issue 8 (August 2019)

Authors:
Herbst, Roy S; Arkenau, Hendrik-Tobias; Santana-Davila, Rafael; Calvo, Emiliano; Paz-Ares, Luis; Cassier, Philippe A; Bendell, Johanna; Penel, Nicolas; Krebs, Matthew G; Martin-Liberal, Juan; Isambert, Nicolas; Soriano, Andres; Wermke, Martin; Cultrera, Jennifer; Gao, Ling; Widau, Ryan C; Mi, Gu;...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 8(2019)
Page Start:
1109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗